Product information

Current status:

Cancelled Post Market

Current status date:

2015-01-01

Original market date: ^{See footnote 1}

2000-01-11

Product name:

EPAXAL

DIN:

02239910 Electronic product monograph is not available

Company:

BERNA BIOTECH LTD
Rehhagstrasse 79
Bern
Bern
Switzerland 3018

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

80:12.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

J07BC02 HEPATITIS A, INACTIVATED, WHOLE VIRUS

Active ingredient group (AIG) number:^{See footnote5}

0126318005